Sullivan & Cromwell is acting for longtime client Merck in its $3.9bn acquisition of US biotech company SpringWorks Therapeutics, which is being repped by Goodwin Procter.

Round dominated by corporate and global financial markets practices also sees three partners elevated in Singapore ...

Report backed by TheCityUK and Freshfields calls for smarter screening to protect security without stifling investment ...